search
Back to results

Guided Surgery for Horizontal Bone Augmentation

Primary Purpose

Edentulous Alveolar Ridge Atrophy

Status
Recruiting
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Horizontal bone augmentation
Sponsored by
KU Leuven
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Edentulous Alveolar Ridge Atrophy focused on measuring implant, bone augmentation, GBR

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • presence of at least one site requiring bone augmentation prior to or simultaneously with implant placement;
  • the above mentioned site should have adjacent teeth both mesially and distally;
  • a history of edentulism in the area of implant treatment of at least 3 months;
  • provision of informed consent.

Exclusion Criteria:

  • unlikely to be able to comply with the study procedures, as judged by the investigator;
  • untreated periodontal disease;
  • known or suspected current malignancy;
  • history of chemotherapy within 5 years prior to study;
  • history of radiation in the head and neck region;
  • history of other metabolic bone diseases;
  • a medical history that makes bone augmentation or implant insertion unfavorable;
  • need for systemic corticosteroids;
  • current or previous use of intravenous bisphosphonates;
  • current or previous use of oral bisphosphonates;
  • history of bone grafting and/or sinus lift in the planned implant area;
  • present alcohol and/or drug abuse;
  • involvement in the planning and conduct of the study;
  • previous enrolment in the present study.

Sites / Locations

  • UZ Leuven Sint Rafaël CampusRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Freehand

Guided

Arm Description

Conventional bone augmentation using a particulate graft material (DBBM) and a collagen barrier membrane.

Bone augmentation performed using the materials as in the Freehand group, but using a surgical guide to help define the shape of the guide.

Outcomes

Primary Outcome Measures

Accuracy of resulting graft, immediately post-operatively.
Linear and volumetric difference between plan and resulting graft, measured on the post-op CBCT.
Accuracy of resulting graft, 6 months after surgery
Linear and volumetric difference between plan and resulting graft, measured on the CBCT taken 6 months after surgery.

Secondary Outcome Measures

Full Information

First Posted
March 8, 2022
Last Updated
March 16, 2022
Sponsor
KU Leuven
Collaborators
ITI Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT05282862
Brief Title
Guided Surgery for Horizontal Bone Augmentation
Official Title
Guided Surgery for Horizontal Bone Augmentation
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Recruiting
Study Start Date
May 28, 2019 (Actual)
Primary Completion Date
March 2023 (Anticipated)
Study Completion Date
March 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
KU Leuven
Collaborators
ITI Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of the research project is to develop a novel protocol for guided bone regeneration (GBR) and assess whether such a patient specific 3D printed guide can improve the accuracy of the resulting bone augmentation when compared to conventional freehand protocols. This study will be an open, prospective, randomized controlled clinical trial. A total of 28 healthy adult patients requiring bone augmentation of an edentulous site with adjacent teeth prior to implant placement will be included in a clinical trial. All patients have to fulfill all inclusion criteria and none of the exclusion criteria. The total study duration for the patient will be around 7 months, from inclusion to final follow-up. A virtual plan representing the ideal shape of the augmentation will be prepared. Bone augmentation guides (molds) will be designed and 3D printed for each case. These molds will encompass the defect and the desired augmentation (including the overfill compensating for the expected resorption) on the buccal aspect, leaving a small access space on the coronal aspect of the defect which will be used to insert the grafting material. Additionally, they will have holes near the mesial, distal and apical edges allowing for fixation of the barrier membrane using pin placement when the mold is in position. Finally, they will extend to the occlusal surface of teeth adjacent to the defect site in order to allow precise positioning and will have a protrusion (handle) on the buccal aspect allowing for easier handling and positioning. The trial will have two groups, a freehand group where conventional bone augmentation surgery will be performed and the clinician will determine the shape of the graft manually, and a guided group where the guide described above will be used. A 50:50 mixture of DBBM and autogenous bone will be used for both groups, resulting in a composite graft. The graft will be covered by a resorbable collagen membrane.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Edentulous Alveolar Ridge Atrophy
Keywords
implant, bone augmentation, GBR

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
28 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Freehand
Arm Type
Active Comparator
Arm Description
Conventional bone augmentation using a particulate graft material (DBBM) and a collagen barrier membrane.
Arm Title
Guided
Arm Type
Experimental
Arm Description
Bone augmentation performed using the materials as in the Freehand group, but using a surgical guide to help define the shape of the guide.
Intervention Type
Procedure
Intervention Name(s)
Horizontal bone augmentation
Intervention Description
Horizontal bone augmentation of a limited span (1-2 teeth) edentulous ridge with neighboring teeth present.
Primary Outcome Measure Information:
Title
Accuracy of resulting graft, immediately post-operatively.
Description
Linear and volumetric difference between plan and resulting graft, measured on the post-op CBCT.
Time Frame
Immediately after surgery
Title
Accuracy of resulting graft, 6 months after surgery
Description
Linear and volumetric difference between plan and resulting graft, measured on the CBCT taken 6 months after surgery.
Time Frame
Six months after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: presence of at least one site requiring bone augmentation prior to or simultaneously with implant placement; the above mentioned site should have adjacent teeth both mesially and distally; a history of edentulism in the area of implant treatment of at least 3 months; provision of informed consent. Exclusion Criteria: unlikely to be able to comply with the study procedures, as judged by the investigator; untreated periodontal disease; known or suspected current malignancy; history of chemotherapy within 5 years prior to study; history of radiation in the head and neck region; history of other metabolic bone diseases; a medical history that makes bone augmentation or implant insertion unfavorable; need for systemic corticosteroids; current or previous use of intravenous bisphosphonates; current or previous use of oral bisphosphonates; history of bone grafting and/or sinus lift in the planned implant area; present alcohol and/or drug abuse; involvement in the planning and conduct of the study; previous enrolment in the present study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mihai Tarce
Phone
+32 16 332483
Email
mihai.tarce@kuleuven.be
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mihai Tarce
Organizational Affiliation
KU Leuven
Official's Role
Principal Investigator
Facility Information:
Facility Name
UZ Leuven Sint Rafaël Campus
City
Leuven
ZIP/Postal Code
3000
Country
Belgium
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mihai Tarce
Phone
+32 16 332483
Email
mihai.tarce@kuleuven.be

12. IPD Sharing Statement

Learn more about this trial

Guided Surgery for Horizontal Bone Augmentation

We'll reach out to this number within 24 hrs